Early research (Phase 1)Ended earlyNCT03701711What this trial is testingLenalidomide in Anti-MAG Neuropathy: Phase 1b StudyWho this might be right forDemyelinating Sensorimotor Neuropathy Ohio State University 11
Not applicableLooking for participantsNCT03918421What this trial is testingImmunoglobulin M (IgM)-Anti-myelin-associated-glycoprotein(MAG) Peripheral Neuropathy StudyWho this might be right forImmunoglobin M Anti-myelin-associated-glycoprotein Peripheral Neuropathy Hospices Civils de Lyon 45
Not applicableEnded earlyNCT02468596What this trial is testingUse of QTRAC Technique to Measure Axonal Excitability in Anti-MAG NeuropathyWho this might be right forPeripheral Neuropathy Associated With Anti-myelin Associated Glycoprotein Antibodies (Anti-MAG Neuropathy) Fondation Ophtalmologique Adolphe de Rothschild 6
Large-scale testing (Phase 3)Looking for participantsNCT05136976What this trial is testingRituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good RespondersWho this might be right forAnti-MAG Neuropathy Centre Hospitalier Universitaire de Saint Etienne 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05065554What this trial is testingACALA-R In Predominantly Demyelinating IgM Mediated NeuropathyWho this might be right forIgM MGUSWaldenstrom MacroglobulinemiaNeuropathy;Peripheral Shayna Sarosiek, MD 12
Testing effectiveness (Phase 2)Looking for participantsNCT07392229What this trial is testingZanubritnib and Anti-MAG NeuropathyWho this might be right forAnti-MAG IgM-associated Demyelinating Polyneuropathy Azienda Ospedaliera di Padova 50
Not applicableUnknownNCT04844203What this trial is testingPrevalence of Orthostatic Tremor in Patients With UnsteadinessWho this might be right forOrthostatic TremorNeuropathy Assistance Publique - Hôpitaux de Paris 100
Testing effectiveness (Phase 2)Ended earlyNCT04568174What this trial is testingFirst in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG NeuropathyWho this might be right forAnti-MAG Neuropathy Polyneuron Pharmaceuticals AG 1
Testing effectiveness (Phase 2)Study completedNCT02967679What this trial is testingSERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot StudyWho this might be right forChronic Inflammatory Demyelinating PolyneuropathyPeripheral NeuropathyCharcot-Marie-Tooth Disease+3 more MedDay Pharmaceuticals SA 15
Not applicableStudy completedNCT03397303What this trial is testingQuantification of Nerve Stiffness in NeuropathiesWho this might be right forChronic Inflammatory Demyelinating PolyneuropathyCharcot-Marie-Tooth Disease, Type IAAnti-MAG Neuropathy Nantes University Hospital 36
Not applicableStudy completedNCT03268161What this trial is testingPrevalence of Genetic Mutations in Patients With Neuropathy Associated With Anti-Myelin-associated Glycoprotein (MAG) AntibodiesWho this might be right forNeuropathy Demyelinating Rennes University Hospital 26
Not applicableLooking for participantsNCT07461896What this trial is testingStudying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDPWho this might be right forCharcot-Marie-ToothCMT1AChronic Inflammatory Demyelinating Polyneuropathy (CIDP)+2 more Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 39
Testing effectiveness (Phase 2)Study completedNCT00050245What this trial is testingRituximab to Treat Neuropathy With Anti-MAG AntibodiesWho this might be right forPolyneuropathies National Institute of Neurological Disorders and Stroke (NINDS) 30